SOURCE: Universal Detection Technology

December 12, 2008 07:00 ET

Universal Detection Technology Received Purchase Order for Bioterrorism Detection Kits and Training Kits From the Washington, D.C. Fire and EMS Department

The Purchase Order Comes Directly From the Department's Homeland Security and Special Operations Division

LOS ANGELES, CA--(Marketwire - December 12, 2008) - Universal Detection Technology ( (OTCBB: UNDT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order for its five-agent bioterrorism detection kits from the Washington, D.C. Fire and Emergency Medical Services (FEMS). The purchase order comes directly from the department's Homeland Security and Special Operations Division. The kits are capable of spot detection of anthrax, ricin toxin, botulinum toxin, plague, and SEBs. The purchase order also includes kits that mimic a "suspicious powder" scenario thus preparing the first responders for a real world event.

The District of Columbia Fire and Emergency Medical Services Department (FEMS) is an all-hazards agency providing emergency medical care and transportation (EMS), fire prevention, fire suppression, hazardous material response, and technical rescue services to residents and visitors in the District of Columbia. FEMS resources are deployed from 33 neighborhood fire stations and include 37 EMS transport units, 33 engine companies, 16 ladder trucks, three heavy-rescue squads, one hazardous materials unit, and one fire Boat Company. 17 of these transport units and 19 of these engine companies are staffed by paramedics providing advanced life support (ALS) care. FEMS responds to over 150,000 incidents a year, an average of 421 a day. FEMS also provides protection for special events that are unique to the nation's capital, such as major demonstrations and the upcoming Presidential Inauguration. In addition, FEMS provides fire and medical protection for Presidential motorcades and helicopter landings.

A report to be released earlier this month by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism says urgent security measures need to be taken soon or the world is likely to undergo an incident of terrorism using weapons of mass destruction within the next five years. "Unless the world community acts decisively and with great urgency, it is more likely than not that a weapon of mass destruction will be used in a terrorist attack somewhere in the world by the end of 2013," the report states in the opening sentence of the executive summary. The report also emphasizes the need of the new administration to prepare the nation against a future bioterrorist attack.

UNDT's anthrax detection equipment has been extensively used by first responders and private industry throughout the country. The equipment has been evaluated by the U.S. DOD as well as the United Kingdom military. The equipment's capacities include:

--  No cross-reactivity with near neighbor strains
--  No cross-reactivity to household powders
--  No set up time
--  No expensive reader needed
--  No decontamination requirements
--  No false positives
--  No false negatives
--  No hook effect

"We are very proud to be providing our detection equipment for protection of the capitol," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer. "This is the second order from the FEMS and it is a testament to the quality and accuracy of our equipment," he added.

For more information, please visit our website at or

Email us at

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information